Age: 0.32
Sex: M
Vaccine: DTP, HIBV
Symptoms: Mental retardation severity unspecified, Nervous system disorder, Nervousness, Otitis media, Psychomotor hyperactivity
Clinical narrative: Information has been received regarding a case in litigation concerning a minor male pt who was exposed to high levels of mercury from thimerosal through exposure to unspecified products. In additional, the pt was exposed to mercury from continually inhaling and ingesting industry mercury emissions from fossil fuel driven power plants. The mercury included in thimerosal laden products and power plant emissions together caused the pt to suffer from serious and permanent neurological injuries. The pt was exposed to airborne mercury vapor and mercury through food chain. The exposure to airborne mercury in the environment through inhalation, the food chain, and other sources contributed to the cumulative mercury toxicity and was a substantial factor in causing his neurological damage. it was noted that the pt had a heightened vulnerability to suffer neurological injuries from industrial mercury as a direct result of thimerosal exposure. As a direct and proximate cause of the toxic mercury exposure to  the pt, minor male was caused to suffer serious and permanent neurological damage which included past and future mental, intellectual, development and neurological incapacity and associated learning disabilities, disorders and impairments. Additional information has been received from medical records concerning an approx 18 month old male with a history of clonus, increased reflexes and hospitalization due to dehydration who on 7/18/1991 and 9/26/1991 was vaccinated with the first and second dosed, respectively of Hib conj vaccine 3rd dose given 6/26/1992 and 4 dose given 11/1/1999. Concomitant vaccinations included the first and second doses, respectively of DPT (3rd dose given 1/26/1992), In approx Nov 1992, the pt was diagnosed with autism as his language decreased and be came unintelligible. His development was slowing in general. He was difficult to handle due to over activity and preservation behavior. On 12/16/1993, the pt was seen by a developmental pediatrician. At that time, the pts mother was concerned he could not talk, She noted he had several words, but quit talking around two years of age. This was the only loss of skills that the mother noticed. At the time of examination, he had no words although he had some immature jargoning. His overall functioning was at the 7-9 month range with characteristics of pervasive developmental disorder (PPD) noted as well as overall development delays in the mental retardation range with language skills being much lower than non language skills. A diagnosis of PPD NOS and moderate mental retardation was made. He did have some temper tantrums which took about 20 minutes to subside. On 11/9/1998, the pt was again seen by a developmental pediatrician. At that time, his mother noted that his nerves were rally bad and that he did not keep still. The pt was being treated with Ritalin. On examination, the pt was noted to be a well nourished, generally uncooperative male in no acute distress. He was preserverative. He speech showed fair to poor intelligibility. He spoke in few words to complete sentences. He had a short attention span. hyperactive and at times attention seeking. He frequently walked on his toes, was echolalic and rock and bit his nails. The pt was fairly non compliant, was inconsistent in identifying number concepts, could not identify shapes and could not draw a cross or square. A diagnosis of autism, ADHD and behavioral problems with non compliance was made. As of 4/3/01, the pt had widely variable ability, ranging from mild to moderate mental retardation to the low average range. As of 3/3/1995, the pt had profound delays in receptive and expressive language and profound delays in phonology respect to his chronological age. It was noted that pt had a articulation disorder. It was also noted that on 12/7/92 and 8/23/95 the pt was vaccianted with the first and second doses, respectively, of MMR II and the first (4/27/98), second (5/27/98) and third (3/26/99) doses, respectively of Hep B vaccine. Medical records received on 9/12/06 contained the following adverse experienced otitis media. Upon internal review, autism, pervasive developmental disorder, moderate mental retardation and neurological injuries and damage were determined to be other important medical events (OMIC). No further information is available. All available medical records will be provided upon request.